Scientific work

Uzm. Dr. Mustafa Serkan Alemdar

25 publications. The source of the information is stated next to each publication.

Back to profile
  1. Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey

    Current Oncology, 2026

    DOI 10.3390/curroncol33040216 PMID 42041735 Open-access full textSource: ORCID

  2. Causal Impact of Hemoglobin Levels on Global Quality of Life in Patients with Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041579 PMID 41753266 Open-access full textSource: ORCID

  3. Extent of Resection and Survival in IDH-Wildtype Glioblastoma: A Dual-Center Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62020385 PMID 41752783 Open-access full textSource: ORCID

  4. Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05158-y PMID 42104040 Open-access full textSource: OpenAlex

  5. Analysing Emotional Well-Being in Cancer Patients: A Natural Language Processing Approach to Correlating Text with Hospital Anxiety and Depression Scale Scores

    Current Oncology, 2026

    DOI 10.3390/curroncol33070400 PMID 42505202 Open-access full textSource: OpenAlex

  6. The Use of Artificial Intelligence Chatbots by Newly Diagnosed Cancer Patients: A Descriptive Phenomenological Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33090563 PMID 42782909 Open-access full textSource: OpenAlex

  7. Association of neoadjuvant treatment-initiation season with pathological response and survival in locally advanced rectal cancer

    Journal of Health Sciences and Medicine, 2026

    DOI 10.32322/jhsm.1991234 Open-access full textSource: OpenAlex

  8. The prognostic value of the Systemic Immune-Inflammation Index at diagnosis in small cell lung cancer

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1996340 Open-access full textSource: OpenAlex

  9. Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach

    Cancers, 2025

    DOI 10.3390/cancers17020233 PMID 39858018 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  10. Predictive value of tumor marker index for pathological complete response following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

    World Journal of Surgical Oncology, 2025

    DOI 10.1186/s12957-025-04081-w PMID 41327416 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  11. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

    Medical Science Monitor, 2024

    DOI 10.12659/msm.943750 PMID 38544312 4 citations (Europe PMC) Open-access full textSource: ORCID

  12. Sarcopenia’s Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

    Medical Science Monitor, 2024

    DOI 10.12659/msm.945240 PMID 39587458 2 citations (Europe PMC) Open-access full textSource: ORCID

  13. Single Apheresis Session on the 4th Day of Granulocyte Colony-Stimulating Factor Administration Seems Convenient to Collect Enough Peripheral Blood Stem Cells from Healthy Donors

    Transfusion Medicine and Hemotherapy, 2024

    DOI 10.1159/000538457 PMID 39664457 Open-access full textSource: ORCID

  14. Solving the puzzle of quality of life in cancer: integrating causal inference and machine learning for data-driven insights

    Health and Quality of Life Outcomes, 2024

    DOI 10.1186/s12955-024-02274-7 PMID 39113111 1 citation (Europe PMC) Open-access full textSource: ORCID

  15. 1271P Integrating machine learning prediction and causal inference analysis to unravel determinants of progression in EGFR-mutant, advanced NSCLC

    Annals of Oncology, 2024

    DOI 10.1016/j.annonc.2024.08.1328 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  16. Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

    Oncology (Switzerland), 2023

    DOI 10.1159/000531576 PMID 37364535 6 citations (Europe PMC) Source: ORCID

  17. Temel Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1765 Source: OpenAlex

  18. Onkolojide İmmünoterapi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1749 Source: OpenAlex

  19. Tacrolimus-Associated Pure Red Cell Aplasia in a Patient With Renal Transplant

    Experimental and Clinical Transplantation, 2022

    DOI 10.6002/ect.2020.0290 PMID 33272158 3 citations (Europe PMC) Source: ORCID

  20. Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia

    Chemotherapy, 2021

    DOI 10.1159/000512314 PMID 33316797 1 citation (Europe PMC) Source: ORCID

  21. Erişkin Ailevi Akdeniz Ateşi Hastalarında Ataksız Dönemdeki Serum Amiloid A’nın Diğer İnflamatuar Belirteçlerle Korelasyonu

    OSMANGAZİ JOURNAL OF MEDICINE, 2021

    DOI 10.20515/otd.938690 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  22. Does Location of the Tumor Affect Prognosis, Survival, and Relapse in Patients With Stage 3 Colorectal Cancers?

    Akdeniz Medical Journal, 2021

    DOI 10.17954/amj.2021.2672 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  23. Impact of Antibiotics and Corticosteroids on The Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma

    Akdeniz Medical Journal, 2021

    DOI 10.17954/amj.2021.2570 Open-access full textSource: OpenAlex

  24. Matrix regenerating agent (RGTA) plays a prominent role in treating persistent epithelial defects

    Journal of EuCornea, 2020

    DOI 10.1016/j.xjec.2020.03.001 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  25. The prognostic significance of neutrophil/lymphocyte ratio in patients with terminal cancer

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.061 Open-access full textSource: OpenAlex